To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
GenoLogics Installs Early Version of Geneus at University of Pittsburgh Genomics and Proteomics Core Laboratories
GenoLogics has announced that Geneus, its solution for the genomics market, was installed at the first customer site, the University of Pittsburgh Genomics and Proteomics Core Laboratories (GPCL).
GPCL currently uses GenoLogics’ Proteus™, a lab and data management solution for proteomics research.
Geneus includes science-specific modules that are purposed for multiple platforms within genomics application areas. It also includes integrations to various genomics instruments and software.
An early access version of Geneus can be installed in genomics labs to manage a variety of genotyping and gene expression workflows including Taqman® processes and the next version of Geneus will include integrations to the Affymetrix GeneChip® platform.
“We are looking forward to using and providing feedback on Geneus. We expect to significantly improve our operational efficiency by incorporating all of our many molecular biology laboratory processes into the Geneus LIMS. This efficiency will be realized in the many small projects that need to be tracked through multiple processes as well as high throughput processes for many samples,” stated Paul Wood, Director, University of Pittsburgh, Genomics and Proteomics Core Laboratories.
“The flexible instrument integration has allowed for us to choose any level of integration from sample tracking to automatic data capture and data management for each of our processes,” said Paul Wood.
The Companuy says that, University of Glasgow’s Sir Henry Wellcome Functional Genomics Facility will be installing Geneus early in 2007. Three additional organizations have also stepped up with orders to purchase Geneus this year, and there are already a number of multiple-science and multi-lab opportunities in our pipeline for Geneus in 2007.